Tuhina Neogi, MD, PhD

Professor, Medicine

Tuhina Neogi
617.358.9650
650 Albany St Evans Biomed Research Ctr

Biography

I am a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. I have had continuous peer-reviewed foundation and NIH funding since 2003, and have over 300 peer-reviewed publications to date. I am a past chair of the FDA Arthritis Advisory Committee, serve(d) on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. My work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year), and the 2022 OARSI Clinical Research Award (in recognition of important contributions to OA research). I have also engaged in developing new classification criteria for a number of rheumatic diseases. In addition to research, clinical work, and teaching, one of my key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, I was awarded the 2016 Robert Dawson Evans Research Mentoring Award. I also developed and led the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers.

Expertise includes:
– Osteoarthritis: epidemiology; risk factors; mechanisms of osteoarthritis-related pain; the role of bone in the pathophysiology of osteoarthritis
– Gout: epidemiology; risk factors and triggers for gout attacks; management of gout; consequences of gout and hyperuricemia
– Classification criteria and outcome measures in rheumatic diseases.
– Novel methodology to address challenging epidemiologic issues

Other Positions

  • Professor, Epidemiology, Boston University School of Public Health
  • Chief, Rheumatology, Medicine, Boston Medical Center
  • Investigator, Framingham Heart Study
  • Member, Arthritis & Autoimmune Diseases Research Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • Section Chief of Rheumatology, Rheumatology, Medicine, Boston University School of Medicine

Education

  • University of Toronto, MD
  • Boston University School of Public Health, PhD
  • McMaster University, BS

Publications

  • Published on 4/11/2022

    Wallace BI, Moore MN, Heisler AC, Muhammad LN, Song J, Clauw DJ, Bingham CO, Bolster MB, Marder W, Neogi T, Wohlfahrt A, Dunlop DD, Lee YC. Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis. Rheumatology (Oxford). 2022 Apr 11; 61(4):1556-1562. PMID: 34293092.

    Read at: PubMed
  • Published on 3/31/2022

    Gl√łersen M, Neogi T, Jafarzadeh SR, Sexton J, Haugen IK. Reply. Arthritis Rheumatol. 2022 Mar 31. PMID: 35358373.

    Read at: PubMed
  • Published on 3/31/2022

    Song J, Muhammad LN, Neogi T, Dunlop DD, Wohlfahrt A, Bolster MB, Bingham CO, Clauw DJ, Marder W, Lee YC. Pain sensitization as a potential mediator of the relationship between sleep disturbance and subsequent pain in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2022 Mar 31. PMID: 35358376.

    Read at: PubMed
  • Published on 3/29/2022

    Neogi T, Hunter DJ, Churchill M, Shirinsky I, White A, Guermazi A, Omata M, Fountaine RJ, Pixton G, Viktrup L, Brown MT, West CR, Verburg KM. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study. Arthritis Res Ther. 2022 Mar 29; 24(1):78. PMID: 35351194.

    Read at: PubMed
  • Published on 3/16/2022

    Helget LN, England BR, Roul P, Sayles H, Petro AD, Neogi T, O'Dell JR, Mikuls TR. Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study. Arthritis Care Res (Hoboken). 2022 Mar 16. PMID: 35294114.

    Read at: PubMed
  • Published on 3/4/2022

    Liew JW, Peloquin C, Tedeschi SK, Felson DT, Zhang Y, Choi HK, Terkeltaub R, Neogi T. Proton Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study. Arthritis Care Res (Hoboken). 2022 Mar 04. PMID: 35245410.

    Read at: PubMed
  • Published on 3/1/2022

    Afinogenova Y, Danve A, Neogi T. Update on gout management: what is old and what is new. Curr Opin Rheumatol. 2022 03 01; 34(2):118-124. PMID: 34907116.

    Read at: PubMed
  • Published on 2/22/2022

    Roemer FW, Felson DT, Stefanik JJ, Rabasa G, Wang N, Crema MD, Neogi T, Nevitt MC, Torner J, Lewis CE, Peloquin C, Guermazi A. Heterogeneity of cartilage damage in Kellgren and Lawrence grade 2 and 3 knees: the MOST study. Osteoarthritis Cartilage. 2022 Feb 22. PMID: 35202808.

    Read at: PubMed
  • Published on 2/9/2022

    Gl√łersen M, Steen Pettersen P, Neogi T, Jafarzadeh SR, Vistnes M, Thudium CS, Bay-Jensen AC, Sexton J, Kvien TK, Hammer HB, Haugen IK. Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis. Arthritis Rheumatol. 2022 Feb 09. PMID: 35137553.

    Read at: PubMed
  • Published on 2/4/2022

    Dalbeth N, Neogi T. Where are the women 'Heroes and Pillars of Rheumatology'? Ann Rheum Dis. 2022 Feb 04. PMID: 35121589.

    Read at: PubMed

View 293 more publications: View full profile at BUMC

View all profiles